Acuson ships AcuNav ultrasound catheter

Article

Rush-Presbyterian-St. Luke's Medical Center in Chicago will receive the first commercial shipment of Acuson's AcuNav diagnostic ultrasound catheter, which was cleared for market by the FDA at the end of last year. The intracardiac ultrasound

Rush-Presbyterian-St. Luke's Medical Center in Chicago will receive the first commercial shipment of Acuson's AcuNav diagnostic ultrasound catheter, which was cleared for market by the FDA at the end of last year.

The intracardiac ultrasound technique works by inserting a catheter through the patient's femoral or jugular vein. Clinicians can then maneuver it into the right atrium or right ventricle of the heart. The catheter uses color Doppler to image blood flow.

Dr. Richard Trohman of Rush-Presbyterian-St. Luke's said the catheter will allow electrophysiologists to perform procedures they were previously unable to do, because the AcuNav images the heart from within. An Acuson Sequoia ultrasound system is also part of the purchase.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.